Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Case Report

Neurobrucellosis: A Case Report with an Unusual Presentation

Author(s): Mostafa Meshref, Yara Amro and Mahmoud A. Ebada*

Volume 16, Issue 1, 2021

Published on: 17 September, 2020

Page: [74 - 78] Pages: 5

DOI: 10.2174/1574891X15999200917153454

Price: $65

Abstract

Background: Brucellosis is a highly infectious multi-systemic zoonosis, and it is caused by Gram-negative bacteria, Brucella. Despite the low incidence of neurobrucellosis, it is the most dangerous consequence of brucellosis.

Case Presentation: A 30-year-old Sudanese male patient presented to our hospital with a complaint of fever associated with confusion for three days. He had signs of meningeal irritation in the form of neck stiffness, positive Kernig’s, and Lesage’s sign. The computerized tomography of the brain was normal. The CSF analysis showed a clear colorless sample with normal tension, decreased glucose, and slightly increased CSF protein level. We reviewed his occupational history; the patient was a farmer with regular contact with cattle and camels. The patient had positive Brucella antibodies for both B. Abortus and B. melitensis with a high titer (1/640). As described in various patents, we administered triple therapy for brucellosis for two weeks. A marked improvement in the conscious level was observed, and the patient was back to normal within a few days post-treatment.

Conclusion: We encouraged physicians to consider the diagnosis of neurobrucellosis with any neurologic sign without a known cause. Our case highlights the importance of occupational history in clinical medicine.

Keywords: Brucella, neurobrucellosis, neurological symptoms, animals, treatment, CSF analysis.

Graphical Abstract
[1]
Zheng N, Wang W, Zhang J-T, et al. Neurobrucellosis. Int J Neurosci 2018; 128(1): 55-62.
[http://dx.doi.org/10.1080/00207454.2017.1363747] [PMID: 28768443]
[2]
Rossi M, Tascini C, Carannante N, Di Caprio G, Sofia S, Iacobello C. Neurobrucellosis: diagnostic and clinical management of an atypical case. New Microbiol 2018; 41(2): 165-7.
[PMID: 29384559]
[3]
Jiao LD, Chu CB, Kumar CJ, et al. Clinical and Laboratory Findings of Nonacute Neurobrucellosis. Chin Med J 2015; 128(13): 1831-3.
[http://dx.doi.org/10.4103/0366-6999.159362] [PMID: 26112728]
[4]
Rodríguez AM, Delpino MV, Miraglia MC, Giambartolomei GH. Immune Mediators of Pathology in Neurobrucellosis: From Blood to Central Nervous System. Neuroscience 2019; 410: 264-73.
[http://dx.doi.org/10.1016/j.neuroscience.2019.05.018] [PMID: 31128159]
[5]
Aziz-Ahari A, Mamishi S, Dadkhah A, Ghazinejadian-Sh FS. Neurobrucellosis in a 9-year-old girl. J Radiol Case Rep 2019; 13(12): 13-9.
[http://dx.doi.org/10.3941/jrcr.v13i12.3734] [PMID: 32184924]
[6]
Yamout BI, Massouh J, Hushaymi I, Zeineddine M, Saab G. Neurobrucellosis presenting as longitudinally extensive transverse myelitis: A case report and review of the literature. Mult Scler Relat Disord 2020; 40101947
[http://dx.doi.org/10.1016/j.msard.2020.101947] [PMID: 32000119]
[7]
Türel O, Şanli K, Hatipoğlu N, Aydoğmuş C, Hatipoğlu H, Şiraneci R. Acute meningoencephalitis due to Brucella: case report and review of neurobrucellosis in children. Turk J Pediatr 2010; 52(4): 426-9.
[PMID: 21043393]
[8]
Ranjbar M, Turgut AT, Nojomi M, Turgut M. Brucellar Spondylitis as a Complication of Brucellosis. In:Neurobrucellosis. Cham: Springer International Publishing 2016; pp. 89-98.
[http://dx.doi.org/10.1007/978-3-319-24639-0_12]
[9]
Maji S, Manjunath N, Bahubali VH, et al. Neurobrucellosis: A neglected entity? An update from tertiary care Neurocentre of South East Asia. J Neurol Sci 2020; 411116683
[http://dx.doi.org/10.1016/j.jns.2020.116683] [PMID: 32001377]
[10]
Chandrashekar N, Shome R. kumaari, V.; Nethravathi; Padmashree.B.S; Maji, S.; Triveni, K.; P, S. “Neurobrucellosis –A Clinical Masquerade in an Indian Scenario; Review of 12 Cases by Correlative Diagnostic Approach. Int J Biol Med 2015; 6: 5143-7.
[11]
Somma T, Caggiano C, Tedeschi E, Turgut AT, Faella F. Brucella Meningitis.In: Turgut M, Haddad FS, de Divitiis O, Eds. In: Neurobrucellosis Clinical, Diagnostic and Therapeutic Features. Cham: Springer International Publishing 2015; pp. 29-35.
[12]
al Deeb SM, Yaqub BA, Sharif HS, Phadke JG. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology 1989; 39(4): 498-501.
[http://dx.doi.org/10.1212/WNL.39.4.498] [PMID: 2927673]
[13]
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352(22): 2325-36.
[http://dx.doi.org/10.1056/NEJMra050570] [PMID: 15930423]
[14]
McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992; 15(4): 582-90.
[http://dx.doi.org/10.1093/clind/15.4.582] [PMID: 1420670]
[15]
Ceran N, Turkoglu R, Erdem I, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region. Braz J Infect Dis 2011; 15(1): 52-9.
[http://dx.doi.org/10.1016/S1413-8670(11)70140-4] [PMID: 21412590]
[16]
Dreshaj S, Shala N, Dreshaj G, Ramadani N, Ponosheci A. Clinical Manifestations in 82 Neurobrucellosis Patients from Kosovo. Mater Sociomed 2016; 28(6): 408-11.
[http://dx.doi.org/10.5455/msm.2016.28.408-411] [PMID: 28144188]
[17]
Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis 2013; 56(10): 1407-12.
[http://dx.doi.org/10.1093/cid/cit072] [PMID: 23446629]
[18]
Gómez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008; 15(6): 1031-3.
[http://dx.doi.org/10.1128/CVI.00424-07] [PMID: 18448622]
[19]
Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect 2013; 19(2): E80-6.
[http://dx.doi.org/10.1111/1469-0691.12092] [PMID: 23210984]
[20]
Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 1996; 75(4): 195-211.
[http://dx.doi.org/10.1097/00005792-199607000-00003] [PMID: 8699960]
[21]
Pascual J, Combarros O, Polo JM, Berciano J. Localized CNS brucellosis: report of 7 cases. Acta Neurol Scand 1988; 78(4): 282-9.
[http://dx.doi.org/10.1111/j.1600-0404.1988.tb03658.x] [PMID: 3223223]
[22]
Shakir . RA.; Al-Din, AS; Araj, GF.; Lulu, A. R.; Mousa, A. R.; Saadah, M. A. Clinical categories of neurobrucellosis. A report on 19 cases. Brain 1987; 110(1): 213-23.
[http://dx.doi.org/10.1093/brain/110.1.213]
[23]
Zhao S, Cheng Y, Liao Y, Zhang Z, Yin X, Shi S. Treatment Efficacy and Risk Factors of Neurobrucellosis. Med Sci Monit 2016; 22: 1005-12.
[http://dx.doi.org/10.12659/MSM.897947] [PMID: 27018084]
[24]
Bodur H, Erbay A, Akinci E, C¸olpan A, C¸evik MA, Balaban N. Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis 2003; 35(2): 94-7.
[http://dx.doi.org/10.1080/0036554021000027000] [PMID: 12693557]
[25]
Bouza E, García de la Torre M, Parras F, Guerrero A, Rodríguez-Créixems M, Gobernado J. Brucellar meningitis. Rev Infect Dis 1987; 9(4): 810-22.
[http://dx.doi.org/10.1093/clinids/9.4.810] [PMID: 3326128]
[26]
al-Idrissi HY, Uwaydah AK, Danso KT, Qutub H, al-Mousa MS. Ceftriaxone in the treatment of acute and subacute human brucellosis. J Int Med Res 1989; 17(4): 363-8.
[http://dx.doi.org/10.1177/030006058901700409] [PMID: 2792556]
[27]
Bahemuka M, Shemena AR, Panayiotopoulos CP, al-Aska AK, Obeid T, Daif AK. Neurological syndromes of brucellosis. J Neurol Neurosurg Psychiatry 1988; 51(8): 1017-21.
[http://dx.doi.org/10.1136/jnnp.51.8.1017] [PMID: 3145961]
[28]
Akdeniz H, Irmak H, Anlar O, Demiröz AP. Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect 1998; 36(3): 297-301.
[http://dx.doi.org/10.1016/S0163-4453(98)94279-7] [PMID: 9661940]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy